SequelSEC

Fortrea Holdings Inc. FTRE

Services-Medical Laboratories · CIK 0001965040 · Fiscal year ends 1231

Revenue
$2.68B
Fiscal year ended 2026-06-30
Operating income
-$10.80M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Fortrea Holdings Inc. (FTRE) reported revenue of $2.68B and net income of -$85.20M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Fortrea Holdings Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

Fortrea Holdings Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$2.68B
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$10.80M
Net income-$85.20M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$77.80M
Income tax expense$7.40M
Diluted EPSUnavailable
Selling, general & administrative$412.40M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Fortrea Holdings Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$168.60M
Total assets$2.71B
Current assets$923.60M
Total liabilities$2.19B
Current liabilities$963.70M
Total equity incl. NCI$524.20M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
Goodwill$950.30M
Long-term debt$1.04B
Accounts payable$54.20M

Cash flow

Fortrea Holdings Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$227.80M
Capital expendituresUnavailable
Investing cash flow-$9.20M
Financing cash flow-$125.70M
Net change in cash$87.40M
Stock-based compensation$61.10M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$78.30M

Derived

Fortrea Holdings Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating margin-0.4%
FCF marginUnavailable
SBC / revenue2.3%
Current ratio0.96x
Revenue YoY growth-2.1%
Net margin-3.2%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equity1.98x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open FTRE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-29View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.